Afinion 2 Analyzer, model #1116986, US refurbished, CLIA waived.
FDA Device Recall #Z-2736-2024 — Class II — June 17, 2024
Recall Summary
| Recall Number | Z-2736-2024 |
| Classification | Class II — Moderate risk |
| Date Initiated | June 17, 2024 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Abbott Diagnostics Technologies AS |
| Location | Oslo |
| Product Type | Devices |
| Quantity | 5 analyzers |
Product Description
Afinion 2 Analyzer, model #1116986, US refurbished, CLIA waived.
Reason for Recall
Five Afinion 2 (AF2) Analyzer were incorrectly market configured as Moderate Complexity and distributed to customers. Use of moderately complex assays by waived laboratories could result in erroneous results.
Distribution Pattern
US Nationwide distribution in the states of AZ, IN, MA, MN, and OH.
Lot / Code Information
Lot #433706, Serial numbers AF20008880, AF20002691, AF20035414, AF20015543 and AF20035460; UDI-DI: 07070060014708.
Other Recalls from Abbott Diagnostics Technologies AS
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2192-2020 | Class II | Power supply provided with Afinion 2, Catalog n... | Mar 23, 2020 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.